Barbara Buttin, M.D., joined City of Hope® Cancer Center in September 2021, where she evaluates and treats patients with gynecologic malignancies, including ovarian, cervical, uterine, vaginal and vulvar cancers.
Dr. Buttin received her medical degree from Drexel University College of Medicine, formerly Hahnemann University, in Philadelphia. She completed a residency in obstetrics and gynecology and a fellowship in gynecologic oncology at Washington University School of Medicine in St. Louis, Missouri.
Patient-focused care is an integral part of improving health outcomes, which is why Dr. Buttin centers her treatment on the individualized needs of the whole patient. Dr. Buttin also incorporates evidence-informed supportive therapies to help combat cancer-related side effects. She has a special interest in minimally invasive surgical techniques, including robotic surgery, having performed over 1,500 cases to date, and the newer application of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer. Dr. Buttin is also focused on growing the clinical trials portfolio at City of Hope to provide patients with more treatment options.
Working in a variety of health care settings, Dr. Buttin has over 15 years of experience as a gynecologic oncologist. She is an active member of several professional organizations including the American College of Obstetricians and Gynecologists and the Society of Gynecologic Oncology.
